NIH Health Information Page Research Results for the Public NIA SeniorHealth.gov NIH Podcast
EurekAlert! - National Institutes of Health  
LINKS

Resources

 

NIH Main

 

NIH Press Releases

 

NIH-Funded News

 
  For News & Research
  NIH Radio
  NIH Podcasts
  eColumn: NIH Research Matters
  NIH News in Health
  Research Results for the Public
 
  Additional Resources
  NIH Home Page
 

About NIH

  NIH Health Information
  Pub Med
  MedlinePlus
  Clinical trials.gov
  More News and Events Sources
  NIH News & Events with Special Interests
 
  Back to EurekAlert!
 

 


Department of Health and Human Services


News from the National Institutes of Health

NIH Press Releases


Key: Meeting M      Journal J      Funder F      Dissertation F

Showing releases 51-75 out of 116 releases.
Click to go to page: [ 1 | 2 | 3 | 4 | 5 ]

Public Release: 16-Sep-2009
Clinical trial of antiretroviral-based HIV prevention strategies for women now under way
A new, large-scale clinical trial is examining whether antiretroviral medications normally used to treat HIV infection can also prevent HIV infection in women when applied as a vaginal gel or taken as oral tablets once daily.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Laura Sivitz
sivitzl@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 15-Sep-2009
New Web site promotes interoperable newborn screening data
The National Library of Medicine today launched the Newborn Screening Coding and Terminology Guide, an important step toward efficient electronic exchange of standard newborn screening data.

Contact: Kathy Cravedi
cravedik@mail.nlm.nih.gov
301-496-6308
NIH/National Library of Medicine

Public Release: 14-Sep-2009
Archives of Ophthalmology
New treatment found to reduce vision loss from central retinal vein occlusion
Scientists have identified the first long-term, effective treatment to improve vision and reduce vision loss associated with blockage of large veins in the eye. This research was part of a multicenter, phase III clinical trial supported by the National Eye Institute at the National Institutes of Health.
NIH/National Eye Institute

Contact: NEI News Office
neinews@nei.nih.gov
301-496-5248
NIH/National Eye Institute

Public Release: 14-Sep-2009
Archives of Ophthalmology
Laser treatment for BRVO is safer than corticosteroid injections and equally effective
Scientists have found that laser therapy is equivalent to two different dosages of corticosteroid medications for treating vision loss from the blockage of small veins in the back of the eye, a condition known as branch retinal vein occlusion (BRVO). Furthermore, laser treatment was shown to have fewer complications for patients.
NIH/National Eye Institute

Contact: NEI News Office
neinews@nei.nih.gov
301-496-5248
NIH/National Eye Institute

Public Release: 13-Sep-2009
Nature Chemistry
Electronic nose sniffs out toxins
Imagine a polka-dotted postage stamp-sized sensor that can sniff out some known poisonous gases and toxins and show the results simply by changing colors. Support for the development and application of this electronic nose comes from the National Institute of Environmental Health Sciences, part of the National Institutes of Health.
NIH/National Institute of Environmental Health Sciences

Contact: Robin Mackar
rmackar@niehs.nih.gov
919-541-0073
NIH/National Institute of Environmental Health Sciences

Public Release: 11-Sep-2009
Early results from clinical trials of 2009 H1N1 influenza vaccines in healthy adults
We are encouraged by reports that are now emerging from various clinical trials of 2009 H1N1 influenza vaccines, conducted by various vaccine manufacturers. We expect additional companies to announce their preliminary trial results shortly. The early data from these trials indicate that 2009 H1N1 influenza vaccines are well tolerated and induce a strong immune response in most healthy adults when administered in a single unadjuvanted 15-microgram dose.
NIH/National Institute of Allergy and Infectious Diseases

Contact: NIAID Office of Communications
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 9-Sep-2009
Lancet
NIAID launches 2009 H1N1 influenza vaccine trial in pregnant women
The first trial testing a candidate 2009 H1N1 influenza vaccine in pregnant women is launching this week, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, announced today.
NIH/National Institute of Allergy and Infectious Diseases

Contact: NIAID Office of Communications
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 3-Sep-2009
NIBIB scientists increase imaging efficiency in cell structure studies
Scientists in the National Institute of Biomedical Imaging and Bioengineering Laboratory of Bioengineering and Physical Science have developed a new technique that allows researchers to visualize fine details of cell structure three-dimensionally in thick sections, thus providing greater insight into how cells are organized and how they function. The work is described in a report published online this week in Nature Methods.
National Institute of Biomedical Imaging and Bioengineering

Contact: Cheryl Fee
feech@mail.nih.gov
301-451-6772
NIH/National Institute of Biomedical Imaging & Bioengineering

Public Release: 3-Sep-2009
New grants expand US infectious disease modeling effort
The National Institutes of Health's Models of Infectious Disease Agent Study adds new research expertise to increase its capacity to simulate disease spread, evaluate different intervention strategies and help inform public health officials and policymakers.
NIH/National Institute of General Medical Sciences

Contact: Emily Carlson
carlsone@nigms.nih.gov
301-496-7301
NIH/National Institute of General Medical Sciences

Public Release: 2-Sep-2009
NIAID funds clinical trials that address the problem of antimicrobial resistance
Scientists are addressing the threat of antimicrobial drug resistance by launching two new clinical trials aimed at prolonging the effectiveness of currently available antibacterial drugs. The concept underlying both studies: less is more.
NIH/National Institute of Allergy and Infectious Diseases

Contact: NIAID Office of Communications
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 1-Sep-2009
PLoS Currents
Studies in animals suggest 2009 H1N1 virus may have biological advantage over seasonal influenza
Preliminary findings in ferrets suggest that the novel 2009 H1N1 influenza virus may outcompete human seasonal influenza viruses, researchers say. Tests in animals showed that levels of the 2009 H1N1 virus rose more quickly than levels of the seasonal virus strains, and the new virus caused more severe disease.
NIH/National Institute of Allergy and Infectious Disease

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 31-Aug-2009
Nature Genetics
NIH study reveals new genetic culprit in deadly skin cancer
Drawing on the power of DNA sequencing, National Institutes of Health researchers have identified a new group of genetic mutations involved in the deadliest form of skin cancer, melanoma. This discovery is particularly encouraging because some of the mutations, which were found in nearly one-fifth of melanoma cases, reside in a gene already targeted by a drug approved for certain types of breast cancer.
National Institutes of Health

Contact: Geoffrey Spencer
spencerg@mail.nih.gov
301-402-0911
NIH/National Human Genome Research Institute

Public Release: 27-Aug-2009
Science
Variants in 3 genes account for most dog coat differences
Variants in just three genes acting in different combinations account for the wide range of coat textures seen in dogs -- from the poodle's tight curls to the beagle's stick-straight fur. A team led by researchers from the National Human Genome Research Institute, part of the National Institutes of Health, reports these findings today in the advance online issue of the journal Science.
NIH/National Human Genome Research Institute

Contact: Geoff Spencer
spencerg@mail.nih.gov
301-402-0911
NIH/National Human Genome Research Institute

Public Release: 26-Aug-2009
Panel assesses evidence for the collection and use of family health history information
Though most Americans are familiar with completing a questionnaire about their family health history when visiting health care providers, an independent panel was convened by the National Institutes of Health this week to critically assess exactly what we know and what we need to learn about how this process relates to improving health. Earlier today, the panel released their findings in a statement.
National Institutes of Health

Contact: Kelli Marciel
Kelli.Marciel@mail.nih.gov
301-496-4819
NIH/National Institutes of Health, Office of Disease Prevention

Public Release: 26-Aug-2009
Nature
New technique could eliminate inherited mitochondrial disease
Researchers funded by the National Institutes of Health have developed an experimental technique with the potential to prevent a class of hereditary disorders passed on from mother to child. The technique, as yet conducted only in nonhuman primates, involves transferring the hereditary material from one female's egg into another female's egg from which the hereditary material has been removed.
National Institutes of Health

Contact: Robert Bock
bockr@mail.nih.gov
301-496-5133
NIH/National Institute of Child Health and Human Development

Public Release: 26-Aug-2009
New England Journal of Medicine
More research on risks and benefits of medical imaging needed
In a new study of nearly 1 million adults between the ages of 18 and 64, nearly 70 percent of participants underwent at least one medical imaging procedure between July 2005 and December 2007, resulting in an average effective dose of radiation nearly double the amount they would otherwise be exposed to from natural sources.

Contact: NHLBI Communications Office
nhlbi_news@nhlbi.nih.gov
301-496-4236
NIH/National Heart, Lung and Blood Institute

Public Release: 25-Aug-2009
JAMA
Gene variant linked to risk of stroke and heart attack for those on Plavix
A new study reports that a gene variant carried by about a third of the population plays a major role in this group's response to an anti-clotting medicine, clopidogrel (Plavix). People with the variant produce a defective version of the CYP2C19 enzyme and are less able to activate the drug, placing them at increased risk for dangerous events like strokes and heart attacks.
NIH/National Institute of General Medical Sciences

Contact: Alisa Zapp Machalek
alisa.machalek@nih.gov
301-496-7301
NIH/National Institute of General Medical Sciences

Public Release: 24-Aug-2009
NIAID to fund new human immune profiling research centers
NIAID is accepting grant applications for a new initiative to establish a consortium of human immune profiling research centers. The purpose of these cooperative centers -- which together will receive funding up to $100 million over five years -- is to characterize the human immune system under normal conditions and to understand how it changes following infection or vaccination.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Julie Wu
wujuli@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 18-Aug-2009
Cancer Research
NIH researchers identify key factor that stimulates brain cancer cells to spread
Researchers funded by the National Institutes of Health have found that the activity of a protein in brain cells helps stimulate the spread of an aggressive brain cancer called glioblastoma multiforme (GBM). In a move toward therapy, the researchers showed that a small designer protein can block this activity and reduce the spreading of GBM cells grown in the laboratory.
National Institutes of Health

Contact: Daniel Stimson
nindspressteam@ninds.nih.gov
301-496-5751
NIH/National Institute of Neurological Disorders and Stroke

Public Release: 17-Aug-2009
PLoS Medicine
Severe sleep apnea tied to increased risk of death
Moderate to severe obstructive sleep apnea is associated with an increased risk of death from any cause in middle-aged adults, especially men, according to new results from a landmark study supported by the National Heart, Lung and Blood Institute of the NIH. The new findings provide the strongest evidence to date of a link between increased risk of death and sleep apnea, a common disorder in which the upper airway is intermittently narrowed during sleep, causing breathing to be difficult or completely blocked.
NIH/National Heart, Lung and Blood Institute

Contact: NHLBI Communications Office
nhlbi_news@nhlbi.nih.gov
301-496-4236
NIH/National Heart, Lung and Blood Institute

Public Release: 16-Aug-2009
Nature
NIH-funded researchers sequence exomes of 12 people
In a pioneering effort that generated massive amounts of DNA sequence data from 12 people, a team supported by the National Institutes of Health has demonstrated the feasibility and value of a new strategy for identifying relatively rare genetic variants that may cause or contribute to disease. The proof-of-concept findings were published online today in the journal Nature.
NIH/National Heart, Lung, and Blood Institute, NIH/National Human Genome Research Institute, NIH/National Institute of Child Health and Human Development

Contact: NHLBI Communications Office
nhlbi_news@nhlbi.nih.gov
301-496-4236
NIH/National Heart, Lung and Blood Institute

Public Release: 13-Aug-2009
Science
Imitation promotes social bonding in primates
Imitation, the old saying goes, is the sincerest form of flattery. It also appears to be an ancient interpersonal mechanism that promotes social bonding and, presumably, sets the stage for relative strangers to coalesce into groups of friends, according to a study by a team of scientists at the National Institutes of Health and two Italian research institutions.
National Institutes of Health

Contact: Robert Bock
bockr@mail.nih.gov
301-496-5133
NIH/National Institute of Child Health and Human Development

Public Release: 12-Aug-2009
New England Journal of Medicine
Gene therapy 1 year later: Patients healthy and maintain early visual improvement
Three young adults who received gene therapy for a blinding eye condition remained healthy and maintained previous visual gains one year later, according to an August online report in Human Gene Therapy. One patient also noticed a visual improvement that helped her perform daily tasks, which scientists describe in an Aug. 13 letter to the editor in the New England Journal of Medicine.
NIH/National Eye Institute, National Institutes of Health

Contact: National Eye Institute
neinews@nei.nih.gov
301-496-5248
NIH/National Eye Institute

Public Release: 11-Aug-2009
JAMA
NIAID scientists study past flu pandemics for clues to future course of 2009 H1N1 virus
A commonly held belief that severe influenza pandemics are preceded by a milder wave of illness arose because some accounts of the flu pandemic of 1918-19 suggested that it may have followed such a pattern. But two NIAID scientists say the existing data are insufficient to conclude decisively that the 1918-19 pandemic was presaged by a milder spring wave, or that the responsible virus had increased in lethality between the beginning and end of 1918.
NIH/National Insitute of Allergy and Infection Diseases

Contact: NIAID Office of Communications
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 10-Aug-2009
Journal of Allergy and Clinical Immunology
NIAID media availability: Still searching for predictors of asthma attacks
A new study of persistent asthma in inner-city adolescents and young adults finds that an extensive set of clinical tests cannot successfully predict the future risk of asthma attacks in participants who both receive care based on current guidelines and adhere to treatment recommendations.
NIH/National Insitute of Allergy and Infection Diseases

Contact: Julie Wu
wujuli@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Showing releases 51-75 out of 116 releases.
    Click to go to page: [ 1 | 2 | 3 | 4 | 5 ]

     
   

HOME    DISCLAIMER    PRIVACY POLICY    CONTACT US
Copyright ©2002 by the American Association for the Advancement of Science